NextGen Healthcare Inc (NASDAQ:NXGN) saw an upside of 0.04% to close Friday at $23.65 after adding $0.01 on the day. The 5-day average trading volume is 1,013,880 shares of the company’s common stock. It has gained $23.73 in the past week and touched a new high 3 times within the past 5 days. An average of 2,447,180 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,241,380.
NXGN’s 1-month performance is 37.18% or $7.29 on its low of $16.41 reached on 08/23/23. The company’s shares have touched a 52-week low of $15.23 and high of $23.73, with the stock’s rally to the 52-week high happening on 09/20/23. YTD, NXGN has achieved 25.93% or $4.87 and has reached a new high 13 times. However, the current price is down -0.34% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
NXGN stock investors last saw insider trading activity on Dec 01.Metcalfe David A (Chief Technology Officer) most recently sold 32,372 shares at $20.58 per share on Dec 01. This transaction cost the insider $666,135. EVP, Commercial Growth, Waters Mitchell, sold 9,783 shares at a price of $20.50 on Nov 08. Then, on Nov 01, Chief Technology Officer Metcalfe David A sold 32,372 shares at a price of $20.00 per share. This transaction amounted to $647,485.
Valuation Metrics
NXGN stock has a beta of 0.89. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.34 while the price-to-book (PB) in the most recent quarter is 3.86, with the price to cash flow ratio at 34.71.
NextGen Healthcare Inc’s quick ratio for the period ended June 29 was 2.15, with the current ratio over the same period at 2.15. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.66, while the total debt to equity was 0.67. In terms of profitability, the gross margin trailing 12 months is 45.46%. The trailing 12-month EBITDA margin is 6.63% while for the period ending June 29, NextGen Healthcare Inc’s operating margin was 1.55%. The firm’s gross profit as reported stood at $311.16 million against revenue of $653.17 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 81.33% to $6.16 million, while revenue of -$25.24 million was 509.74% off the previous quarter. Analysts expected NXGN to announce $0.22 per share in earnings in its latest quarter, but it posted $0.24, representing a 9.10% surprise. EBITDA for the quarter stood at more than $17.83 million. NXGN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 457.95 million, with total debt at $274.01 million. Shareholders hold equity totaling $67.02 million.
Let’s look briefly at NextGen Healthcare Inc (NXGN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 September was 89.18% to suggest the stock is trending Overbought, with historical volatility in this time period at 1.64%.
The stock’s 5-day moving average is $23.65, reflecting a +0.30% or $0.07 change from its current price. NXGN is currently trading +32.42% above its 20-day SMA, +37.42% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +41.28% and SMA200 by+17.49%.
Stochastic %K and %D was 98.35% and 98.80% and the average true range (ATR) pointed at 0.29. The RSI (14) points at 86.87%, while the 14-day stochastic is at 97.78% with the period’s ATR at 0.36. The stock’s 9-day MACD Oscillator is pointing at 0.03 and 0.25 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for NextGen Healthcare Inc (NASDAQ: NXGN), Cantor Fitzgerald launched coverage with an Overweight rating. Analysts offering their rating for NXGN stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate NXGN as a “sell,”, while 7 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
